Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Richard Champlin MD

Richard Champlin MD

Professor of Medicine, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

Richard Champlin, MD, is Professor of Medicine at MD Anderson Cancer Center. He served for over 30 years as Chairman, Department of Stem Cell Transplantation and Cellular Therapy.  He has been the President of the American Society of Blood and Marrow Transplantation as well as the Center for International Center for Blood and Marrow Transplantation Research. His work focuses on translational research to assess novel approaches for hematopoietic transplantation, to enhance engraftment, hematopoietic/immune recovery and disease free survival in patients with hematologic malignancies, and development of cellular immunotherapies.

Recent Contributions to PracticeUpdate:

  1. Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation

Recently Updated